These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25225461)

  • 1. Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders.
    Perreau M; Vigano S; Bellanger F; Pellaton C; Buss G; Comte D; Roger T; Lacabaratz C; Bart PA; Levy Y; Pantaleo G
    J Exp Med; 2014 Sep; 211(10):2033-45. PubMed ID: 25225461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired CD8(+) T cell responses upon Toll-like receptor activation in common variable immunodeficiency.
    de Lollo C; de Moraes Vasconcelos D; da Silva Oliveira LM; de Oliveira Titz T; Carneiro-Sampaio M; Jacob CM; da Silva Duarte AJ; Sato MN
    J Transl Med; 2016 May; 14(1):138. PubMed ID: 27188997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+CD25+Foxp3+ T regulatory cells, Th1 (CCR5, IL-2, IFN-γ) and Th2 (CCR4, IL-4, Il-13) type chemokine receptors and intracellular cytokines in children with common variable immunodeficiency.
    Kutukculer N; Azarsiz E; Aksu G; Karaca NE
    Int J Immunopathol Pharmacol; 2016 Jun; 29(2):241-51. PubMed ID: 26684629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential impact of PD-1 and/or interleukin-10 blockade on HIV-1-specific CD4 T cell and antigen-presenting cell functions.
    Porichis F; Hart MG; Zupkosky J; Barblu L; Kwon DS; McMullen A; Brennan T; Ahmed R; Freeman GJ; Kavanagh DG; Kaufmann DE
    J Virol; 2014 Mar; 88(5):2508-18. PubMed ID: 24352453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin replacement therapy in the treatment of patients with common variable immunodeficiency disease: an open-label prospective study.
    Kasztalska K; Ciebiada M; Cebula-Obrzut B; Górski P
    Clin Drug Investig; 2011; 31(5):299-307. PubMed ID: 21473654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory B cells in CVID patients fail to suppress multifunctional IFN-γ+ TNF-α+ CD4+ T cells differentiation.
    Vlkova M; Ticha O; Nechvatalova J; Kalina T; Litzman J; Mauri C; Blair PA
    Clin Immunol; 2015 Oct; 160(2):292-300. PubMed ID: 26232673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated levels of activated CD4 T cells in common variable immunodeficiency: association with clinical findings.
    Carbone J; Sarmiento E; Micheloud D; Rodríguez-Molina J; Fernández-Cruz E
    Allergol Immunopathol (Madr); 2006; 34(4):131-5. PubMed ID: 16854344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis.
    Liao W; Zheng H; Wu S; Zhang Y; Wang W; Zhang Z; Zhou C; Wu H; Min J
    Am J Nephrol; 2017; 46(5):371-379. PubMed ID: 29069649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of programmed death receptor-1 signaling restores expression of mostly proinflammatory cytokines in anergic cytomegalovirus-specific T cells.
    Dirks J; Egli A; Sester U; Sester M; Hirsch HH
    Transpl Infect Dis; 2013 Feb; 15(1):79-89. PubMed ID: 23176118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression.
    Hatam LJ; Devoti JA; Rosenthal DW; Lam F; Abramson AL; Steinberg BM; Bonagura VR
    Clin Cancer Res; 2012 Apr; 18(7):1925-35. PubMed ID: 22322668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective IL-4 signaling in T cells defines severe common variable immunodeficiency.
    Taraldsrud E; Fevang B; Jørgensen SF; Moltu K; Hilden V; Taskén K; Aukrust P; Myklebust JH; Olweus J
    J Autoimmun; 2017 Jul; 81():110-119. PubMed ID: 28476239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppression of Human Adipose-Derived Stem Cells on T Cell Subsets via the Reduction of NF-kappaB Activation Mediated by PD-L1/PD-1 and Gal-9/TIM-3 Pathways.
    Zhou K; Guo S; Tong S; Sun Q; Li F; Zhang X; Qiao Y; Liang G
    Stem Cells Dev; 2018 Sep; 27(17):1191-1202. PubMed ID: 29978730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responsiveness of HIV-specific CD4 T cells to PD-1 blockade.
    Porichis F; Kwon DS; Zupkosky J; Tighe DP; McMullen A; Brockman MA; Pavlik DF; Rodriguez-Garcia M; Pereyra F; Freeman GJ; Kavanagh DG; Kaufmann DE
    Blood; 2011 Jul; 118(4):965-74. PubMed ID: 21652684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction.
    D'Souza M; Fontenot AP; Mack DG; Lozupone C; Dillon S; Meditz A; Wilson CC; Connick E; Palmer BE
    J Immunol; 2007 Aug; 179(3):1979-87. PubMed ID: 17641065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity.
    Braun NA; Celada LJ; Herazo-Maya JD; Abraham S; Shaginurova G; Sevin CM; Grutters J; Culver DA; Dworski R; Sheller J; Massion PP; Polosukhin VV; Johnson JE; Kaminski N; Wilkes DS; Oswald-Richter KA; Drake WP
    Am J Respir Crit Care Med; 2014 Sep; 190(5):560-71. PubMed ID: 25073001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low percentages of regulatory T cells in common variable immunodeficiency (CVID) patients with autoimmune diseases and its association with increased numbers of CD4+CD45RO+ T and CD21
    López-Herrera G; Segura-Méndez NH; O'Farril-Romanillos P; Nuñez-Nuñez ME; Zarate-Hernández MC; Mogica-Martínez D; Yamazaki-Nakashimada MA; Staines-Boone AT; Santos-Argumedo L; Berrón-Ruiz L
    Allergol Immunopathol (Madr); 2019; 47(5):457-466. PubMed ID: 31103252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic immunodeficiency in mice lacking RasGRP1 results in CD4 T cell immune activation and exhaustion.
    Priatel JJ; Chen X; Zenewicz LA; Shen H; Harder KW; Horwitz MS; Teh HS
    J Immunol; 2007 Aug; 179(4):2143-52. PubMed ID: 17675473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IVIg immune reconstitution treatment alleviates the state of persistent immune activation and suppressed CD4 T cell counts in CVID.
    Paquin-Proulx D; Santos BA; Carvalho KI; Toledo-Barros M; Barreto de Oliveira AK; Kokron CM; Kalil J; Moll M; Kallas EG; Sandberg JK
    PLoS One; 2013; 8(10):e75199. PubMed ID: 24130688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune Checkpoint Blockade Restores HIV-Specific CD4 T Cell Help for NK Cells.
    Porichis F; Hart MG; Massa A; Everett HL; Morou A; Richard J; Brassard N; Veillette M; Hassan M; Ly NL; Routy JP; Freeman GJ; Dubé M; Finzi A; Kaufmann DE
    J Immunol; 2018 Aug; 201(3):971-981. PubMed ID: 29934472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular cytokine production by human CD4+ and CD8+ T cells from normal and immunodeficient donors using directly conjugated anti-cytokine antibodies and three-colour flow cytometry.
    North ME; Ivory K; Funauchi M; Webster AD; Lane AC; Farrant J
    Clin Exp Immunol; 1996 Sep; 105(3):517-22. PubMed ID: 8809143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.